Investor alert: shareholder class action lawsuit filed against kyverna therapeutics, inc. (nasdaq: kytx); dicello levitt llp encourages investors with losses to discuss their options with counsel

San diego, dec. 12, 2024 (globe newswire) -- a class action lawsuit has been filed on behalf of all persons and entities who purchased or otherwise acquired kyverna therapeutics, inc. (nasdaq: kytx) (“kyverna” or the “company”) common stock pursuant and/or traceable to the company's registration statement issued in connection with its initial public offering (“ipo”) held on february 8, 2024. the kyverna lawsuit charges the company, certain of its current and former senior executives and directors, and the underwriters of kyverna's ipo with violations of the federal securities laws (collectively, “defendants”).
KYTX Ratings Summary
KYTX Quant Ranking